Eris Lifesciences net profit drops 4.5% to Rs 89 crore in Q1FY25 0 02.08.2024 18:16 Economictimes.indiatimes.com Eris acquired Biocon Biologics' domestic branded formulation business for Rs 1,242 crore in Q4FY24 and dermatology and nephrology units in Q3FY24 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
